These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13181602)

  • 1. [Anticoagulant therapy of chronic obliterating peripheral arteriopathy].
    TATTONI G; MALCHIODI C
    Arch Ital Chir; 1954; 77(3):169-88. PubMed ID: 13181602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lytic cocktail in therapy of chronic obliterating arteriopathy].
    D'ANCONA G
    Minerva Chir; 1955 Feb; 10(3):120-6. PubMed ID: 14369777
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic anticoagulant therapy of arteriosclerotic peripheral arteriopathy].
    CASTRO CM; DE SOLDATI L; GRILLI H
    Rev Argent Cardiol; 1957; 24(4):210-28. PubMed ID: 13579351
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a new drug with sympatholytic and analgesic action in therapy of chronic juvenile and arteriosclerotic peripheral obliterating arteriopathy].
    GUAGLIANO G; STOPPANI L
    Minerva Chir; 1958 Nov; 13(21):1282-6. PubMed ID: 13622298
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bogomoletz serum in therapy of chronic peripheral obliterating arteriopathy].
    VERGANI G
    Gazz Med Ital; 1958 Jan; 117(1):4-5. PubMed ID: 13524597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined intraarterial therapy of lesions caused by peripheral arteriopathy; effect of pretreatment with hydergine on the action of other drugs].
    BECATTINI U; SCARSELLI E
    Minerva Cardioangiol; 1957 May; 5(5):188-91. PubMed ID: 13483176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic innovations in chronic peripheral arteriosclerotic obliterating arteriopathies].
    GUAGLIANO G; STOPPANI L; CONTI PG
    Angiologia; 1960; 12():323-36. PubMed ID: 13709323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin tolerance and blood coagulation factors in obliterating arteriopathy].
    WALCHER A; GOOSSENS N; HESS H; STUMPF W
    Klin Wochenschr; 1960 Sep; 38():952. PubMed ID: 13782625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Small doses of intra-arterial heparin in therapy of some peripheral arterial diseases].
    BUTTO M; MASETTO I
    Acta Med Patav; 1954; 14(2):281-92. PubMed ID: 13217714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intra-arterial curare therapy of peripheral obliterating arteriopathy].
    ENRIA G
    Minerva Cardioangiol; 1957 Oct; 5(10):461-3. PubMed ID: 13503741
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparin therapy of cardiovascular diseases].
    BELIGAN G; BRAUNER R; PRODESCU V; SORIN E; STEFANESCU C
    Med Interna (Bucur); 1956 Jul; 8(3):380-5. PubMed ID: 13399636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications and results of intra-arterial therapy of peripheral vascular diseases].
    FRANCO P
    Minerva Cardioangiol; 1954; 2(2):77-90. PubMed ID: 13185090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tentative interpretation of the mechanism of action of heparin in small dosage by intra-arterial route in various peripheral vascular diseases].
    BUTTO' M; MASETTO I; MENOZZI L
    Riforma Med; 1955 Jan; 69(3):61-5. PubMed ID: 14372779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intra-arterial fluorescein test in some peripheral vascular diseases before and after intra-arterial administration of small doses of heparin].
    MASETTO I
    Acta Med Patav; 1957; 17(1):67-78. PubMed ID: 13487241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with Sintroma "Geigy" as an anticoagulant, especially in the long-term treatment of peripheral arterial obliteration].
    EJRUP B
    Sven Lakartidn; 1961 Feb; 58():257-74 passim. PubMed ID: 13726231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is obliterating arteriopathy of the lower limbs still the poor member of the arterial disease family? What can be done?].
    Blacher J
    J Mal Vasc; 2007 Apr; 32(2):73-4. PubMed ID: 17498900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with Sintroma "Geigy" as an anticoagulant used mainly in the long-term treatment of peripheral arterial obliterations. II. The therapeutic effects of long-term treatment].
    EJRUP B
    Sven Lakartidn; 1961 Feb; 58():426-41. PubMed ID: 13726230
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the use of the gastric mucoprotein in chronic obliterating arteriopathy of the extremities].
    MORPURGO M
    G Gerontol; 1960 Nov; 8():1013-5. PubMed ID: 13772793
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the arteriolo-capillary circulation in subjects of chronic peripheral obliterating arteriopathy after treatment with 1, 1-(beta-hydroxypropyl)-theobromine].
    GUAGLIANO G; STOPPANI L; VITTORI F
    Minerva Med; 1959 Nov; 50():3815-9. PubMed ID: 13829927
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary results in the use of trypsin in the treatment of chronic peripheral obliterating arterial diseases].
    CONTI A; MAZZEO F
    Minerva Chir; 1957 May; 12(9):419-25. PubMed ID: 13451265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.